Take a look at the following health care stocks that showed higher volumes than usual: NanoVibronix, Inc., Catalent Inc, Iovance Biotherapeutics, Inc..
Here's an update with information from the last trading session: Leading equity indices in the US declined as after dropping 0.59%, Nasdaq closed at 10,984. S&P 500 lost 0.16% and ended the session at 3,957.63.
Why trading volume matters?
Trading volume is simply the total number of shares traded including both buy and sell orders. If a stock has appreciated on high volume, it is more likely to be a sustained move compared to an appreciation with low volume. Typically, high volume trading sessions are considered significant occurrences and closely watched by traders.
Though trading was down yesterday, some health care stocks reached high volumes. Here is an update.
NanoVibronix | 1,646% higher than rolling average NanoVibronix suffers weak session with 21% loss; downside halted at 44.45 cents
Yesterday's trading volume peaked at 25.24 million shares, thereby blitzing the daily average of 1.53 million by 1,646%. After ending Monday at 63.29 cents, NanoVibronix declined to 44.45 cents yesterday before closing at 50 cents, thereby losing 21% in total.
Catalent | 170% above rolling average Catalent ended yesterday at $47.18, a 0.55% increase
Catalent outpaced its average daily trading volume (4.19 million) with 7.12 million shares traded yesterday. Catalent ended Monday's session at $46.92. yesterday started with an increase to $49.09, but dropped back and closed at $47.18.
Catalent hit a significant low of $41.39 around 5 days ago, but has since recovered 13.36%. So far in 2022, it has been under-performing the S&P 500 by 41.15%. Catalent's market cap is currently $8.49 billion with an average daily trading volume of 4.19 million shares. Catalent's last revenue report was $1 billion with an EPS of 34 cents.
Iovance Biotherapeutics | 147% higher than rolling average After 10 sombre days of declines, Iovance Biotherapeutics was up 3.19% yesterday
With 5.15 million shares traded yesterday, Iovance Biotherapeutics beat its daily average by 147% to cap off a frenetic trading day. An 11 day downtrend is ongoing for Iovance Biotherapeutics. yesterday may indicate a change of direction; Iovance Biotherapeutics spiked to $6.31 yesterday and consolidated before initiating a fresh rally to $6.14. This comes following Monday's session in which it closed at $5.95.
The Californian biopharmaceutical startup is now trading 44.39% below its 3-month high of $20.16. Iovance Biotherapeutics's market cap is currently $969.14 million with an average daily trading volume of 3.51 million shares.
— Average trading volume refers to a 21-day rolling average.